XTNT · Xtant Medical Holdings, Inc.
$0.31
-0.01 (-2.24%)
At close · Aug 14
Market Cap
$42.79M
Shares
140.29M
Xtant Medical Holdings, Inc. Earnings Call Transcripts
Every quarterly earnings call for Xtant Medical Holdings, Inc. (XTNT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲5%
$14.46M
−$2.35M
'22 Q3
22-11-03
▲9.3%
$15.27M
−$2.21M
'22 Q4
23-03-07
▲38.5%
$17.94M
−$2.08M
'23 Q1
23-05-04
▲32.4%
$20.23M
−$2.19M
'23 Q2
23-08-01
▲73%
$25.02M
$9.23M
'23 Q3
23-11-09
▲84.1%
$28.11M
−$4.30M
'23 Q4
23-12-31
▲55.3%
$27.87M
−$4.40M
'24 Q1
24-04-01
▲48%
$29.94M
−$3.86M
'24 Q2
24-08-08
▲11.7%
$27.94M
−$5.02M
'24 Q3
24-11-12
▲12.1%
$31.51M
−$3.16M
'24 Q4
25-03-06
▲18%
$32.90M
$58,000
'25 Q1
25-05-12
▲18.3%
$35.41M
$3.55M
'25 Q2
25-08-12
▲19%
$33.26M
$1.31M
'25 Q3
25-11-10
▲2.7%
$32.36M
$57,000
'25 Q4
26-03-31
▼36.5%
$20.88M
−$3.09M
'26 Q1
26-05-13
LATEST
▼35%
$23.03M
−$9.41M
'26 Q2
26-08-11
Earnings call
FY26 · Q2
2026-08-11
Xtant Medical Holdings, Inc. Q2 FY2026 Earnings Call
Revenue
$23.03M
▼ 35% YoY Diluted EPS
$-0.07
▼ 450% YoY Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Xtant Medical Holdings, Inc. Q1 FY2026 Earnings Call
Confident tone
Trivium Shaped product launch
Companion Spine divestiture and balance sheet
HEMOBLAST Bellows / Dilon Technologies license
Revenue
$20.88M
▼ 36.5% YoY Diluted EPS
$-0.02
Gross margin
57.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-31
Xtant Medical Holdings, Inc. Q4 FY2025 Earnings Call
Positive tone
Companion Spine divestiture and strategic refocus
Hardware segment outlook
Self-sustainability and financial discipline
Revenue
$32.36M*
▲ 2.7% YoY Gross margin
54.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-10
Xtant Medical Holdings, Inc. Q3 FY2025 Earnings Call
Confident tone
New product launches and innovation
Amniotic membrane reimbursement landscape
Pending Coflex/Cofix divestiture to Companion Spine
Revenue
$33.26M
▲ 19% YoY Diluted EPS
$0.01
Gross margin
66.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Xtant Medical Holdings, Inc. Q2 FY2025 Earnings Call
Confident tone
Biologics growth and new product launches
Sale of non-core COFLEX/Paradigm OUS assets
Gross margin outlook
Revenue
$35.41M
▲ 18.3% YoY Diluted EPS
$0.02
Gross margin
68.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Xtant Medical Holdings, Inc. Q1 FY2025 Earnings Call
Confident tone
Biologics vertical integration and new product launches
Revenue growth and guidance
Cash flow and capital needs
Revenue
$32.90M
▲ 18% YoY Diluted EPS
$0.00
Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-06
Xtant Medical Holdings, Inc. Q4 FY2024 Earnings Call
Positive tone
Gross margin pressure
Biologics business and vertical integration
Cost-cutting and self-sustainability
Revenue
$31.51M*
▲ 12.1% YoY Gross margin
50.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Xtant Medical Holdings, Inc. Q3 FY2024 Earnings Call
Confident tone
New Product Launches
Profitability and Adjusted EBITDA
In-House Biologics Manufacturing
Revenue
$27.94M
▲ 11.7% YoY Diluted EPS
$-0.04
▼ 157.1% YoY Gross margin
58.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Xtant Medical Holdings, Inc. Q2 FY2024 Earnings Call
Revenue
$29.94M
▲ 48% YoY Diluted EPS
$-0.03
Gross margin
62.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-01
Xtant Medical Holdings, Inc. Q1 FY2024 Earnings Call
Confident tone
Distribution & Contract Access
Profitability & Gross Margin
New Product Introductions
Revenue
$27.87M
▲ 55.3% YoY Diluted EPS
$-0.03
Gross margin
62.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Xtant Medical Holdings, Inc. Q4 FY2023 Earnings Call
Revenue
$28.11M*
▲ 84.1% YoY Gross margin
61.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Xtant Medical Holdings, Inc. Q3 FY2023 Earnings Call
Revenue
$25.02M
▲ 73% YoY Diluted EPS
$0.07
Gross margin
61.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Xtant Medical Holdings, Inc. Q2 FY2023 Earnings Call
Revenue
$20.23M
▲ 32.4% YoY Diluted EPS
$-0.02
Gross margin
61.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Xtant Medical Holdings, Inc. Q1 FY2023 Earnings Call
Revenue
$17.94M
▲ 38.5% YoY Diluted EPS
$-0.02
Gross margin
58.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-07
Xtant Medical Holdings, Inc. Q4 FY2022 Earnings Call
Revenue
$15.27M*
▲ 9.3% YoY Gross margin
54.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Xtant Medical Holdings, Inc. Q3 FY2022 Earnings Call
Revenue
$14.46M
▲ 5% YoY Diluted EPS
$-0.03
Gross margin
54.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Xtant Medical Holdings, Inc. Q2 FY2022 Earnings Call
Revenue
$15.28M
▲ 2% YoY Diluted EPS
$-0.02
Gross margin
54.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Xtant Medical Holdings, Inc. Q1 FY2022 Earnings Call
Revenue
$12.96M
▲ 3.3% YoY Diluted EPS
$-0.03
Gross margin
58.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-08
Xtant Medical Holdings, Inc. Q4 FY2021 Earnings Call
Revenue
$13.97M*
▼ 0.3% YoY Gross margin
55.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Xtant Medical Holdings, Inc. Q3 FY2021 Earnings Call
Revenue
$13.78M
▼ 1.7% YoY Diluted EPS
$-0.02
Gross margin
52.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Xtant Medical Holdings, Inc. Q2 FY2021 Earnings Call
Revenue
$14.97M
▲ 42.2% YoY Diluted EPS
$-0.01
Gross margin
63.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
Xtant Medical Holdings, Inc. Q1 FY2021 Earnings Call
Revenue
$12.54M
▼ 15.1% YoY Diluted EPS
$0.00
Gross margin
64.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Xtant Medical Holdings, Inc. Q4 FY2020 Earnings Call
Revenue
$14.02M*
▼ 17.4% YoY Gross margin
64.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-01
Xtant Medical Holdings, Inc. Q3 FY2020 Earnings Call
Revenue
$14.02M
▼ 10.8% YoY Diluted EPS
$-0.10
Gross margin
66.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-03
Xtant Medical Holdings, Inc. Q2 FY2020 Earnings Call
Revenue
$10.53M
▼ 31.1% YoY Diluted EPS
$-0.19
Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Xtant Medical Holdings, Inc. Q1 FY2020 Earnings Call
Revenue
$14.78M
▼ 11.7% YoY Diluted EPS
$-0.19
Gross margin
65.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Xtant Medical Holdings, Inc. Q4 FY2019 Earnings Call
Revenue
$16.96M*
▼ 7.1% YoY Gross margin
67.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
1453593
CUSIP
98420P308
13F (30d)
30 filings
30 filers
Visit website
Investor relations